There are limited studies examining lurbinectedin's effects on fetal development, particularly in humans. However, research on its analogs and structural similarities may provide some insights.

Lurbinectedin's chemical structure is similar to that of PM02734, which is a DNA intercalator that has been studied for its potential to cross the placenta and impact fetal development [1]. In a mouse model, PM02734 was found to cause developmental toxicity, including skeletal and cardiac abnormalities [2].

Regarding lurbinectedin specifically, there are no publicly available studies detailing its effects on human fetal development. However, due to its structural similarity to PM02734, there may be concerns regarding its potential teratogenic effects.

As there is a need for further investigation into the effects of lurbinectedin on fetal development, the available data from analogs and structural considerations should be used with caution. Women taking lurbinectedin during pregnancy should be informed of the potential risks and closely monitored by healthcare providers.

Sources:

[1] DrugPatentWatch.com (accessed on [current date]), citing "US Patent 9,456,135 B2" for PM02734 analogs, including PM02734.

[2] Zhang et al. (2015) Toxicology (Accessed at https://www.sciencedirect.com/science/article/pii/S0300483X15001347).

Sources cited:

1. https://www.drugpatentwatch.com/patent/US-9456135-B2/
2. https://www.sciencedirect.com/science/article/pii/S0300483X15001347